FilingReader Intelligence
Dalian Bio-Chem cited for internal control deficiencies
August 15, 2025 at 05:16 PM UTC•By FilingReader AI
Dalian Bio-Chem Co received regulatory action on August 14, 2025, for internal control deficiencies in fund, procurement, and contract management, violating corporate governance guidelines.
Chairman Liu Xianwu and chief financial officer Wang Xiliang were deemed primarily responsible and received warning letters. The company must rectify issues within 30 days.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:603360•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Dalian Bio-Chem publishes news
Free account required • Unsubscribe anytime